EFFICACY AND SAFETY OF DABIGATRAN ETEXILATE VERSUS VITAMIN K ANTAGONIST FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN ROUTINE CLINICAL PRACTICE: RECOVERY DVT/PE PROSPECTIVE GLOBAL COHORT STUDY

2020 
RE-COVERY DVT/PE is a multicenter, international, observational study of patients with deep vein thrombosis/pulmonary embolism (DVT/PE), comparing outcomes with dabigatran vs. vitamin K antagonists (VKAs). The main outcomes were International Society on Thrombosis and Haemostasis major or
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []